| Five Top Obesity Stocks to Buy and Hold Long Term | 09/12 11:50 | 247wallst.com |
| CORRECTION – Altimmune Presents Results of a Phase 2 MRI-Based Body Composition Sub-Study at 60th Annual Meeting of the European Association for the Study of Diabetes | 09/10 13:09 | globenewswire.com |
| ALT5 Sigma Reports 104% Year-Over-Year Increase in Transaction Volume to Over US$1.250 Billion for First Eight Months of 2024 | 09/10 11:00 | accesswire.com |
| Altimmune Presents Results of a Phase 2 MRI-Based Body Composition Sub-Study at 60th Annual Meeting of the European Association for the Study of Diabetes | 09/10 07:45 | globenewswire.com |
| ALT5 Sigma to Exhibit at iFX Bangkok September 16-18, 2024 | 09/09 08:00 | accesswire.com |
| Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 60th Annual Meeting of the European Association for the Study of Diabetes | 09/03 07:30 | globenewswire.com |
| Altimmune: Emerging Position In Competitive Space, But Risks Remain | 08/27 11:26 | seekingalpha.com |
| ALT5 Sigma Appoints Peter Tassiopoulos as Chief Executive Officer | 08/26 08:45 | accesswire.com |
| ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024 | 08/23 11:00 | accesswire.com |
| ALT5 Sigma Reports Fiscal Financial Results for Second Quarter 2024 | 08/19 18:30 | accesswire.com |